|
Albert Hofmann and conference organizer Dieter Hagenbach pose in Albert’s garden. |
| |
|
I would say it’s his really big heart, his curiosity for life and the
universe in general, the way he went from a scientist, i.e. a chemist
at Sandoz, to a philosophically inspiring person, a wise human
being, another “Old Man from the Mountain” . . . |
|
| |
| |
Celebrate LSD and Albert Hofmann in January
MAPS President Rick Doblin Interviews Conference Organizer Dieter Hagenbach
This January, MAPS will be sending a crew of researchers to Basel,
Switzerland for a symposium on LSD to celebrate the 100th birthday
of Albert Hofmann. The conference hosts an amazing lineup of over
50 speakers including Stanislav Grof Ph.D., Ram Dass, the Shulgin’s,
Alex Grey and Albert Hofmann himself. MAPS President Rick Doblin will
be speaking, as will researchers Michael Mithoefer M.D., John Halpern
M.D., Charles Grob M.D. and Valerie Mojeiko. The symposium will present
an in-depth review of all aspects of LSD: informing and discussing
history, experiences, implications, and assessing risks and benefits.
Following is an interview with the conference’s organizer,
Dieter Hagenbach conducted by MAPS President Rick Doblin. Doblin and
Hagenbach discuss the conference, Hofmann, and thoughts on the future
of psychedelics.
Hagenbach, born in 1943, studied architecture and art before beginning
a career as a bookseller and publisher, and later as a literary agent
and publicist. He is director of the Gaia Media Foundation, a non-profit
organization which strives to convey a holistic and up-to-date understanding
of the potential of the human consciousness using electronic media,
lectures, exhibitions, and symposiums.
Rick Doblin: What do you hope to accomplish with the conferenceS
Dieter Hagenbach: A much-needed broader understanding about what
LSD is, what it did, and what it did not, what it influenced, and
the impact it has made—in the arts, in music, society, science,
politics, etc—All this for the benefit of both the audience (experts
and interested lay persons) and the media.
RD: What motivated you personally to undertake the major amount of
work that a conference of this magnitude will require?
DH: As mentioned in our announcement, LSD has been, still is, and
will always be a challenge. The reasons and explanations why are so
manifold that I can’t name them all.
On a professional level, as a publisher and as the founder of the
Gaia Media Foundation, the human consciousness and evolution have
always fascinated me. That’s one motivation for the symposium
we are staging. It’s also certainly the personal experiences
with LSD, which eventually led me to a much better understanding of
myself and the rest of the world and the universe. Experiences which
gave me, along with meditation, yoga, and other practices, unique
and incomparably deep insights, which only to outline would take much
more time and space; especially the notorious, but after all life-changing,
“religious” experience. So that’s another motivation.
Last but not least, it’s my long friendship with Albert Hofmann,
and the countless wonderful and rewarding conversations we had from
back in the 1970s up to now, as well as the editing and publishing
his book “Insights— Outlooks”. Or the many occasions
when I saw him at his home with people like William S. Burroughs,
R. Gordon Wasson, Ann and Sasha Shulgin, to name just a few. Of course,
this has been shaping my life and my work, and is still another motivation
to organize a symposium about LSD, something which, quite naturally,
leads far beyond those 3 letters . .
RD: What do you think it is about Albert that he has inspired so
many people?
DH: I don’t think that I am the right person to answer this
question. I would say it’s his really big heart, his curiosity
for life and the universe in general, the way he went from a scientist,
i.e. a chemist at Sandoz, to a philosophically inspiring person, a
wise human being, another “Old Man from the Mountain”
. .
RD: Assuming you could conduct any sort of research you wanted to
with LSD and with psilocybin, what would it be?
DH: I would want an increase of, and the appropriate support on all
levels and from all sides for the research which has started (and
subsequently been suppressed) since the discovery of LSD. From the
early experiments and studies in Canada, at Harvard, and in Prague,
to the present-day research and studies planned in Switzerland and
the US. As to private “research” I’d wish for more—and
much needed—competent information, education, and guidance,
which would finally allow safety and legal use of this most potent
of all psychoactive substances.
RD: Basically, Western culture stomped on mystery ceremonies with
psychedelics about 1600 years ago when the Eleusinian Mysteries were
shut down by the Catholic Church. Ever since, psychedelics have been
kept underground, except for a brief period in the 20th century when
psychedelic research flowered before being shut down again. Do you
think that we really have a good chance now of integrating these experiences
and substances into legal frameworks, or is the human species still
not ready?
DH: I would say that the human species always used and was always
ready for psychedelics. There’s clear evidence in almost every
culture throughout human history, and this is mentioned and outlined
in hundreds of books and papers. But humanity and culture has always
been the subject of manipulation and thus suppression. So we always
have a good chance, again and again!
|
| |
| Winter 2009 |
Vol. 18, No. 3 |
MAPS 2008 Financial Report |
| Summer 2008 |
Vol. 18, No. 2 |
Phoenix Rising: A Review of MAPS Research |
| Winter 2008 |
Vol. 18, No. 1 |
Special Edition: Technology and Psychedelics |
| Winter 2007 |
Vol. 17, No. 3 |
MAPS 06-07 Fiscal Yearly Report |
| Autumn 2007 |
Vol. 17, No. 2 |
Special Edition: Psychedelics and Self-Discovery |
| Spring/Summer 2007 |
Vol. 17, No. 1 |
The Chrysalis Stage |
| Winter 2006-7 |
Vol. 16, No. 3 |
Low Maintenance/High Performance |
| Autumn 2006 |
Vol. 16, No. 2 |
Technologies of Healing |
| Spring 2006 |
Vol. 16, No. 1 |
MAPS' 20th Anniversary |
| Winter 2005 |
Vol. 15, No. 3 |
MAPS final year as a teenager |
| Summer 2005 |
Vol. 15, No. 2 |
Israel Conference: MDMA/PTSD Research |
| Spring 2005 |
Vol. 15, No. 1 |
Accelerating flow of work and time |
| Autumn 2004 |
Vol. 14, No. 2 |
Rites of Passage: Kids and Psychedelics |
| Summer 2004 |
Vol. 14, No. 1 |
10 stamps and $250,000 |
| Winter 2003 |
Vol. 13, No. 2 |
Holy Fire |
| Spring 2003 |
Vol. 13, No. 1 |
60th Anniversary of the Discovery
of LSD |
| Autumn 2002 |
Vol. 12, No. 3 |
Vision |
| Summer 2002 |
Vol. 12, No. 2 |
"From celebration to frustration,
and back again." |
| Spring 2002 |
Vol. 12, No. 1 |
Sex, Spirit & Psychedelics 2002 |
| Autumn 2001 |
Vol. 11, No. 2 |
"In the future, it will be called
Despair." |
| Spring 2001 |
Vol. 11, No. 1 |
"A Tidal Wave of Ecstasy!" |
| Autumn 2000 |
Vol. 10, No. 3 |
Creativity 2000 |
| Summer 2000 |
Vol. 10, No. 2 |
Endings and Beginnings |
| Spring 2000 |
Vol. 10, No. 1 |
Making History in Slow Motion |
| Winter 1999/00 |
Vol. 9, No. 4 |
To the Ends of the Earth for MDMA
Research... |
| Autumn 1999 |
Vol. 9, No. 3 |
MAPS' long-standing efforts to conduct... |
| Summer 1999 |
Vol. 9, No. 2 |
MAPS has come full circle... |
| Spring 1999 |
Vol. 9, No. 1 |
Patience, persistence and passion |
| Winter 1998/99 |
Vol. 8, No. 4 |
One of special pleasures of directing
MAPS... |
| Autumn 1998 |
Vol. 8, No. 3 |
The Ayahuasca Issue (with Hofmann
interview) |
| Summer 1998 |
Vol. 8, No. 2 |
Emotionally Powerful Anecdotes... |
| Spring 1998 |
Vol. 8, No. 1 |
Death Has a Way of Focusing One's
Attention |
| Autumn 1997 |
Vol. 7, No. 4 |
Celebration is in Order |
| Summer 1997 |
Vol. 7, No. 3 |
Time Horizons |
| Spring 1997 |
Vol. 7, No. 2 |
Synchronicity |
| Winter 1996/97 |
Vol. 7, No. 1 |
Learning to Crawl |
| Autumn 1996 |
Vol. 6, No. 4 |
An Invitation for Dialogue |
| Summer 1996 |
Vol. 6, No. 3 |
Budding Research |
| New Year 1996 |
Vol. 6, No. 2 |
Sending Down Roots |
| Autumn 1995 |
Vol. 6, No. 1 |
Baby Steps |
| Summer 1995 |
Vol. 5, No. 4 |
Opportunity Amidst Obstacles |
| Winter 1994/95 |
Vol. 5, No. 3 |
Clinical Trials and Tribulations |
| Autumn 1994 |
Vol. 5, No. 2 |
Building Towards Clinical Trials |
| Summer 1994 |
Vol. 5, No. 1 |
Politics and Protocols: In Search
of a Balance |
| Spring 1994 |
Vol. 4, No. 4 |
Laying the Groundwork |
| Winter 1993/94 |
Vol. 4, No. 3 |
A Time of Tests |
| Summer 1993 |
Vol. 4, No. 2 |
So Close Yet So Far |
| Spring 1993 |
Vol. 4, No. 1 |
Remembrance and Renewal |
| Winter 1992/93 |
Vol. 3, No. 4 |
Forging New Alliances |
| Summer 1992 |
Vol. 3, No. 3 |
Building on Common Ground |
| Spring 1992 |
Vol. 3, No. 2 |
Small Steps, Gradual Progress, New
Opportunities |
| Winter 1991/92 |
Vol. 3, No. 1 |
The Rekindling of a Thousand Points
of Light |
| Summer 1991 |
Vol. 2, No. 2 |
MDMA protocol development with cancer patients |
| Winter 1990/91 |
Vol. 2, No. 1 |
MAPS' Swiss pharmacologically-assisted psychotherapy
conference |
| Autumn 1990 |
Vol. 1, No. 3 |
What and Who is MAPS? |
| Summer 1989 |
Vol. 1, No. 2 |
Switzerland Leads the Way |
| Summer 1988 |
Vol. 1, No. 1 |
MDMA can become a legal medicine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|